§ 721.1737 - Benzotriazole derivative.

(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as a benzotriazole derivative (PMN P-94-2061) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.

(2) The significant new uses are:

(i) Protection in the workplace. Requirements as specified in § 721.63 (a)(4), and (b)(concentration set at 5.0 percent) and (c). The following paragraphs apply during manufacturing and processing: (a)(5)(ii), (a)(5)(iv), and (a)(5)(v). The following paragraphs apply during use: (a)(5)(iii), (a)(5)(viii), (a)(5)(ix), (a)(5)(x), (a)(5)(xi), and (a)(6)(ii).

(ii) Hazard communication program. Requirements as specified in § 721.72 (a), (b), (c), (d), (e)(concentration set at 5.0 percent), (f), (g)(1)(vi), (g)(2)(ii), (g)(2)(iii), and (g)(2)(iv). The following additional statements shall appear on each label and MSDS required by this paragraph: This substance may cause kidney effects. This substance may cause liver effects. This substance may cause neurotoxicity effects. This substance may cause blood effects.

(iii) Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(q).

(iv) Release to water. Requirements as specified in § 721.90 (a)(1) and (b)(1).

(b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.

(1) Recordkeeping. Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), (i), (j) and (k) are applicable to manufacturers, importers, and processors of this substance.

(2) Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.

(3) Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to this section.